Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019;96:1048–50.

Article  PubMed  Google Scholar 

GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1151–1210.

Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–90.

Article  PubMed  PubMed Central  Google Scholar 

United States Renal Data System. USRDS annual data report: epidemiology of kidney disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2022.

Google Scholar 

Kaysen G. Dyslipidemia in chronic kidney disease: causes and consequences. Kidney Int. 2006;70:S55–8.

Article  Google Scholar 

Harper CR, Jacobson TA. Managing dyslipidemia in chronic kidney disease. J Am Coll Cardiol. 2008;51:2375–84.

Article  CAS  PubMed  Google Scholar 

Schaeffner ES, Kurth T, Curhan GC, Glynn RJ, Rexrode KM, Baigent C, Buring JE, Gaziano JM. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol. 2003;14:2084–91.

Article  CAS  PubMed  Google Scholar 

Chen SC, Hung CC, Kuo MC, Lee JJ, Chiu YW, Chang JM, Hwang SJ, Chen HC. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One. 2013;8:e55643.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Voskamp PWM, van Diepen M, Dekker FW, Hoogeveen EK. Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients. Sci Rep. 2018;8:3130.

Article  PubMed  PubMed Central  Google Scholar 

Rahman M, Yang W, Akkina S, Alper A, Anderson AH, Appel LJ, He J, Raj DS, Schelling J, Strauss L, et al. Relation of serum lipids and lipoproteins with progression of CKD: the CRIC study. Clin J Am Soc Nephrol. 2014;9:1190–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chawla V, Greene T, Beck GJ, Kusek JW, Collins AJ, Sarnak MJ, Menon V. Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:1582–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ginsberg HN, Packard CJ, Chapman MJ, Borén J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42:4791–806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. Eur Heart J. 2021;42:4324–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castañer O, Pintó X, Subirana I, Amor AJ, Ros E, Hernáez Á, Martínez-González M, Corella D, Salas-Salvadó J, Estruch R, et al. Remnant cholesterol, Not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712–24.

Article  PubMed  Google Scholar 

Hu X, Liu Q, Guo X, Wang W, Yu B, Liang B, Zhou Y, Dong H, Lin J. The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus. Cardiovasc Diabetol. 2022;21:117.

Article  PubMed  PubMed Central  Google Scholar 

Huh JH, Roh E, Lee SJ, Ihm SH, Han KD, Kang JG. Remnant cholesterol is an independent predictor of type 2 diabetes: a nationwide population-based cohort study. Diabetes Care. 2023;46:305–12.

Article  CAS  PubMed  Google Scholar 

Varbo A, Benn M, Tybjærg-Hansen A, Jørgensen AB, Frikke-Schmidt R, Nordestgaard BG. Remnant cholesterol as a causal risk factor for ischemic heart disease. J Am Coll Cardiol. 2013;61:427–36.

Article  CAS  PubMed  Google Scholar 

Yan P, Xu Y, Miao Y, Bai X, Wu Y, Tang Q, Zhang Z, Yang J, Wan Q. Association of remnant cholesterol with chronic kidney disease in middle-aged and elderly Chinese: a population-based study. Acta Diabetol. 2021;58:1615–25.

Article  CAS  PubMed  Google Scholar 

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, Alonso N, Cambray S, Del Pino MD, Mauricio D, et al. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opin Ther Targets. 2019;23:619–30.

Article  PubMed  Google Scholar 

Hayashi T, Hirano T, Taira T, Tokuno A, Mori Y, Koba S, Adachi M. Remarkable increase of apolipoprotein B48 level in diabetic patients with end-stage renal disease. Atherosclerosis. 2008;197:154–8.

Article  CAS  PubMed  Google Scholar 

Jansson Sigfrids F, Dahlström EH, Forsblom C, Sandholm N, Harjutsalo V, Taskinen MR, Groop PH. Remnant cholesterol predicts progression of diabetic nephropathy and retinopathy in type 1 diabetes. J Intern Med. 2021;290:632–45.

Article  CAS  PubMed  Google Scholar 

Wu Z, Yu S, Zhu Q, Li Z, Zhang H, Kang X, Xu Z, Miao X, Liu X, Li X, et al. Association of baseline and cumulative remnant cholesterol with incidence of diabetic nephropathy: a longitudinal cohort study. Diabetes Res Clin Pract. 2022;191:110079.

Article  CAS  PubMed  Google Scholar 

Kim HK, Song SO, Noh J, Jeong IK, Lee BW. Data configuration and publication trends for the Korean national health insurance and health insurance review & assessment database. Diabetes Metab J. 2020;44:671–8.

Article  PubMed  PubMed Central  Google Scholar 

Kim YH, Kang JG, Lee SJ, Han KD, Ihm SH, Cho KH, Park YG. Underweight increases the risk of end-stage renal diseases for type 2 diabetes in Korean population: data from the national health insurance service health checkups 2009–2017. Diabetes Care. 2020;43:1118–25.

Article  CAS  PubMed  Google Scholar 

Huh JH, Han KD, Cho YK, Roh E, Kang JG, Lee SJ, Ihm SH. Remnant cholesterol and the risk of cardiovascular disease in type 2 diabetes: a nationwide longitudinal cohort study. Cardiovasc Diabetol. 2022;21:228.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ahn E, Shin DW, Yang HK, Yun JM, Chun SH, Suh B, Lee H, Son KY, Cho B. Treatment gap in the national health-screening program in Korea: claim-based follow-up of statin use for sustained hypercholesterolemia. J Korean Med Sci. 2015;30:1266–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA. 2013;310:2061–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384:626–35.

Article  CAS  PubMed  Google Scholar 

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–104.

Article  PubMed  Google Scholar 

Roh E, Noh E, Hwang SY, Kim JA, Song E, Park M, Choi KM, Baik SH, Cho GJ, Yoo HJ. Increased risk of type 2 diabetes in patients with thyroid cancer after thyroidectomy: a nationwide cohort study. J Clin Endocrinol Metab. 2022;107:e1047–56.

Article  PubMed  Google Scholar 

Shin J, Han K, Jung JH, Park HJ, Kim W, Huh Y, Kim YH, Kim DH, Kim SM, Choi YS, et al. Age at menopause and risk of heart failure and atrial fibrillation: a nationwide cohort study. Eur Heart J. 2022;43:4148–57.

Article  CAS  PubMed  Google Scholar 

Yoo JE, Jeong SM, Yeo Y, Jung W, Yoo J, Han K, Lee CM, Park JH, Park KW, Shin DW. Smoking cessation reduces the risk of heart failure: a nationwide cohort study. JACC Heart Fail. 2023;11:277–87.

Article  PubMed  Google Scholar 

Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604–12.

Article  PubMed  PubMed Central  Google Scholar 

Organization WH. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.

Kim KK, Haam JH, Kim BT, Kim EM, Park JH, Rhee SY, Jeon E, Kang E, Nam GE, Koo HY, et al. Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean society for the study of obesity. J Obes Metab Syndr. 2023;32:1–24.

Article  PubMed  PubMed Central  Google Scholar 

Tonelli M, Riella MC. Chronic kidney disease and the aging population. Kidney Int. 2014;85:487–91.

Article  PubMed  Google Scholar